News | August 08, 2007

CAD Marks 96 Percent of Cancers Detected with FFDM

August 9, 2007 - Hologic Inc. announced that, according to a recent independent peer-reviewed study published in the July issue of Radiology, computer aided detection correctly marked 99 (96.1 percent) of 103 consecutive asymptomatic breast cancers detected with digital mammographic screening, with an acceptable false marker rate (1.80 false CAD marks per patient). The CAD system (ImageChecker M1000 version 3.1) used in this study was from Hologic’s R2 Technology subsidiary.

Yang and co workers, from the Seoul National University Medical Research Center, reported that the R2 CAD system “marked all 44 breast cancers that manifested as microcalcifications only, all 23 breast cancers that manifested as a mass with microcalcifications and 32 (89 percent) of 36 lesions that appeared as a mass only.” “We are pleased that this study (the first to be published on R2 digital CAD by an independent medical facility) showed such strong results. Of particular note, CAD correctly marked the single invasive lobular carcinoma lesion and 67 of 71 (94.4 percent) of invasive ductal carcinomas, of which 22 had a component of DCIS. As digital mammography gains wider acceptance, R2’s CAD will continue to be a valuable tool to assist radiologists in the earlier detection of breast cancer”, said Dr. Ronald A. Castellino, R2 Technology’s chief medical officer.

Hologic|R2 continues to develop and refine it’s CAD solutions and is currently marketing ImageChecker V8.3 for digital mammography.

For more information: and

Related Content

ClearRead CT Nearing 50 Installations Milestone
News | Computed Tomography (CT) | June 22, 2017
June 22, 2017 — Riverain Technologies announced that it is now processing data from nearly 50...
Carestream Spotlights New Imaging Analytics Tools for Preventative Care at SIIM 2017, Clinical Collaboration Platform
News | Computer-Aided Detection Software | May 15, 2017
Carestream Health is demonstrating new imaging analytics tools that are being added to its Clinical Collaboration...
Low-Cost AI Could Screen for Cervical Cancer Better Than Humans
Feature | Artificial Intelligence | April 25, 2017
Artificial intelligence (AI) is already exceeding human abilities. Self-driving cars use AI to perform some tasks more...
Parascript and Volpara Establish Partnership for Improved Early Cancer Detection
News | Computer-Aided Detection Software | April 11, 2017
Parascript LLC announced a new partnership with Volpara Solutions, creator of Volpara Density automated breast density...
iCAD, PowerLook Tomo Detection, computer-aided detection software, CAD, digital breast tomosynthesis, DBT, RSNA 2017
Technology | Computer-Aided Detection Software | March 27, 2017
March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S.
Parascript, AccuDetect CAD for Mammography, computer-aided detection, NCoBC 2017
News | Computer-Aided Detection Software | March 15, 2017
Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las...
artificial intelligence, radiology, five reasons, Signify Research report
News | Artificial Intelligence | December 19, 2016
December 19, 2016 — A recent report from market research firm Signify Research presents five reasons why...
Sponsored Content | Videos | Artificial Intelligence | December 16, 2016
At RSNA 2016, the key buzzwords were “deep learning,” “machine learning” and “artificial intelligence.” Vendors and m
Sponsored Content | Videos | Artificial Intelligence | December 08, 2016
Mark Michalski, M.D., director of the Center for Clinical Data Science at Massachusetts General Hospital, explains th
Technology | Computer-Aided Detection Software | December 07, 2016
QView Medical Inc. announced that it received U.S. Food and Drug Administration (FDA) approval in early November for...
Overlay Init